dr. rini on the efficacy of axitinib and pembrolizumab in rcc
Published 6 years ago • 656 plays • Length 1:19Download video MP4
Download video MP3
Similar videos
-
1:34
dr. rini on pembrolizumab plus axitinib in rcc
-
3:28
dr rini on a biomarker analysis for pembrolizumab/axitinib in advanced rcc
-
1:03
dr. rini on managing the toxicity of pembrolizumab plus axitinib in mrcc
-
1:04
dr. rini discusses pembrolizumab plus axitinib in mrcc
-
2:16
dr. rini on axitinib for treatment of metastatic renal cell carcinoma
-
4:48
renal cell carcinoma: everything you need to know
-
5:10
real-world treatment outcomes of 1l axitinib pembrolizumab in patients with advanced rcc in the us
-
4:34
edoxudine
-
2:06
dr. rini discusses tivozanib in advanced rcc
-
1:12
dr. rini describes axitinib's and sorafenib's side effects
-
0:43
dr. rini on the results from his axitinib and sorafenib trial
-
0:38
dr. rini explains the axitinib integration process
-
0:44
dr. rini on the axitinib and sorafenib trial vegf focus
-
1:56
dr. cost on pembrolizumab plus axitinib in patients with rcc
-
1:17
dr. vaishampayan on axitinib plus pembrolizumab in advanced rcc
-
0:43
dr. rini discusses the vegf targeted agent axitinib
-
0:49
dr. rini describes hypertension as a biomarker in rcc
-
1:33
dr. rini on challenges with biomarkers in rcc
-
0:59
dr. rini on cytoreductive nephrectomy in rcc
-
2:31
axitinib plus pembrolizumab in advanced rcc
-
2:23
overview of a phase iii trial of pembrolizumab plus axitinib in rcc
-
0:53
dr. rini on standards of care for advanced rcc